Diomed Holdings, Inc. to Host Conference Call Announcing Third Quarter 2006 Financial Results

  
    
  
  
    
      Diomed Holdings, Inc. (AMEX: DIO), a leading developer and 
      marketer of minimally invasive medical technologies, including its 
      patented EndoVenous Laser Treatment (EVLT®) 
      for varicose veins, today announced that it will host a conference call 
      to review the company’s third quarter ended 
      September 30, 2006 financial results.
    
    
      The call will be conducted on Thursday, October 26, 2006, at 10:00 a.m. 
      (ET) and will be hosted by James A. Wylie, Jr., President and Chief 
      Executive Officer, and David B. Swank, Chief Financial Officer. The 
      company's financial results are scheduled to be released earlier that 
      day.
    
    
      Interested parties may access the conference call by dialing 
      866-831-6162 (domestic) or 617-213-8852 (international), participant 
      pass code 146644724. The call will also be available via web cast at www.diomedinc.com.
    
    
      If you are unable to participate, an audio digital replay of the call 
      will be available from Thursday, October 26, 2006, 12:00 p.m. ET, until 
      Thursday, November 2, 2006, 12:00 p.m. ET. The digital replay can be 
      accessed by dialing 1-888-286-8010, (domestic) or 1-617-801-6888 - 
      (international), using pass code 92289158. A web archive will also be 
      available during this time period at www.diomedinc.com.
    
    
      About Diomed
    
    
      Diomed develops and commercializes minimal and micro-invasive medical 
      procedures that use its proprietary laser technologies and disposable 
      products. Diomed’s EVLT® 
      laser vein ablation procedure is used in varicose vein treatments. 
      Diomed also provides photodynamic therapy (PDT) for use in cancer 
      treatments, and dental and general surgical applications. The EVLT® 
      procedure and the Company’s related products 
      were cleared by the United States FDA in January of 2002. Along with 
      lasers and single-use procedure kits for its EVLT® 
      laser vein treatment, the Company provides its customers with state of 
      the art physician training and practice development support. Additional 
      information is available on the Company’s 
      website: www.evlt.com.
    
    
      EVLT® is a registered trademark of Diomed 
      Inc., Andover, MA.
    
  
Diomed Holdings, Inc. (AMEX: DIO), a leading developer and
marketer of minimally invasive medical technologies, including its
patented EndoVenous Laser Treatment (EVLT(R)) for varicose veins,
today announced that it will host a conference call to review the
company's third quarter ended September 30, 2006 financial results.

   The call will be conducted on Thursday, October 26, 2006, at 10:00
a.m. (ET) and will be hosted by James A. Wylie, Jr., President and
Chief Executive Officer, and David B. Swank, Chief Financial Officer.
The company's financial results are scheduled to be released earlier
that day.

   Interested parties may access the conference call by dialing
866-831-6162 (domestic) or 617-213-8852 (international), participant
pass code 146644724. The call will also be available via web cast at
www.diomedinc.com.

   If you are unable to participate, an audio digital replay of the
call will be available from Thursday, October 26, 2006, 12:00 p.m. ET,
until Thursday, November 2, 2006, 12:00 p.m. ET. The digital replay
can be accessed by dialing 1-888-286-8010, (domestic) or
1-617-801-6888 - (international), using pass code 92289158. A web
archive will also be available during this time period at
www.diomedinc.com.

   About Diomed

   Diomed develops and commercializes minimal and micro-invasive
medical procedures that use its proprietary laser technologies and
disposable products. Diomed's EVLT(R) laser vein ablation procedure is
used in varicose vein treatments. Diomed also provides photodynamic
therapy (PDT) for use in cancer treatments, and dental and general
surgical applications. The EVLT(R) procedure and the Company's related
products were cleared by the United States FDA in January of 2002.
Along with lasers and single-use procedure kits for its EVLT(R) laser
vein treatment, the Company provides its customers with state of the
art physician training and practice development support. Additional
information is available on the Company's website: www.evlt.com.

   EVLT(R) is a registered trademark of Diomed Inc., Andover, MA.